Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-09-17 DOI:10.1080/21645515.2024.2389576

Sendu Seid, Teferi Gebru Gebremeskel

引用次数: 0

Abstract

COVID-19 vaccination in African people living with human immunodeficiency virus remains understudied, with limited research in Ethiopia that fails to consider contextual differences. To assess upta...

查看原文本刊更多论文

埃塞俄比亚亚的斯亚贝巴 Bole 次城市卫生机构中人类免疫缺陷病毒感染者对 COVID-19 疫苗的接种率、不良反应及相关因素

对非洲人类免疫缺陷病毒感染者接种 COVID-19 疫苗的研究仍然不足，在埃塞俄比亚进行的研究有限，而且没有考虑到环境差异。为了评估非洲人感染人类免疫缺陷病毒后接种 COVID-19

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.